ESAOTE LAUNCHED MyLab™Eight
Esaote, which is one of the world leaders in the manufacture of diagnostic ultrasound systems and probes and has been on the market for more than 30 years, launched MyLab™Eight, the flagship platform in its Ultrasound portfolio. Esaote MyLab™Eight Ultrasound system defines a new standard in Image Quality for confident diagnosis. MyLab™Eight is the culmination of Esaote’s commitment to R&D in order to meet the increasing demands of modern healthcare in terms of outstanding image quality and ease of use.
Confident Diagnosis - MyLab™Eight incorporates the new eMPowered Engine to optimize high-density single crystal transducers to enable images to be captured deeper in the body with unprecedented quality for difficult-to-scan patients.
The new WideView visualization technology offers sharp diagnostic image clarity with enhanced spatial and contrast resolution.
With high-frequency imaging, advanced hemodynamic evaluation tools such as XFlow and HD CFM, and complete portfolio of probes, Esaote offers solutions covering Radiology, Cardiovascular, Obstetrics and Gynecology as well as Interventional and Surgery.
Productivity and Comfort - Esaote’s focus on the prevention of work-related musculoskeletal disorders runs through a new approach to design: from award-winning appleprobe transducers to MyLab™Remote, the remote system user interface App that allows MyLab™Eight to be controlled via smartphone or tablet. The touchscreen-based workflow offers intuitive commands so that the system can be easily operated in any scanning condition.
Wireless and wired connectivity offer numerous data saving and transmission options.
Advanced tools - A full assortment of advanced tools, including QElaXto shear wave quantitative elastography, Virtual Navigator real-time Fusion Imaging, RF-based QIMT, QAS arterial stiffness quantification, CnTI™ contrast enhanced ultrasound, and many more, make MyLab™Eight a unique solution for everyday clinical needs and the most demanding research activity.
Read more about MyLab™Eight - For more information please visit our online resources at www.esaote.com
With €280 million in consolidated sales in 2015, Esaote Group is a leading player in the biomedical equipment sector, with a particular focus on ultrasound, dedicated magnetic resonance, and software for managing the diagnostic process. Esaote has about 1.250 employees with manufacturing and research units in Italy and the Netherlands. Esaote is internationally recognized as one of the “Top Ten” diagnostic imaging companies in the world, and enjoys the co-operation of worldwide scientific and clinical research centers and universities. Esaote has filed more than 120 international patents.